Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC7A5-AS1 is a long non-coding RNA transcribed antisense to the SLC7A5 gene. It does not code for a protein, but may regulate SLC7A5 expression and influence cellular metabolism and proliferation. Its exact biological function and disease relevance remain largely uncharacterized. SLC7A5-AS1 is sometimes mistaken for the SLC7A5 protein transporter (LAT1), a well-known drug target, but should not be considered a canonical therapeutic target itself. SLC7A5-AS1 is a non-protein-coding transcript and not a transporter, receptor, or enzyme. No drugs, mechanisms of action, clinically validated biomarkers, or safety concerns are documented for SLC7A5-AS1; relevant literature focuses mainly on its potential regulatory function in cancer and gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC7A5 antisense RNA 1 (SLC7A5-AS1).